Beyond Antibody LLP
About Beyond Antibody LLP
Data last updated:
Beyond Antibody LLP is a limited liability partnership (LLP) based in Bangalore, Karnataka, India. It operates in the research and development sector. It was incorporated on 20 April 2016 and has been in existence for over 10 years.
The LLP is registered with the Registrar of Companies (ROC), Bangalore, under LLPIN AAG-1989. Its GSTIN is 29AAQFB3050P2ZV (Karnataka). The LLP holds 2 GST registrations, of which 1 is active.
The LLP has a total obligation of contribution of ₹1 Lakh. It is led by designated partners Manjula Das and Sujan Kumar Dhar.
Its latest statement of accounts is for the year ended 31 March 2025. The registered office is at S – 005 Krishna Greens Krishna Temple Road Dodda Bommasandra, Bangalore, Karnataka, India – 560097.
The LLP is associated with 1 brand: Beyond Antibody.
- EmailLocked
- TelephoneLocked
- WebsiteLocked
- Social MediaLocked
- Registered AddressS – 005 Krishna Greens Krishna Temple Road Dodda Bommasandra, Bangalore, Karnataka, India – 560097
- IndustryResearch & Development, Research & Development
- Company details, directors and signatories
- Historical financials and ratios
- Shareholding pattern and group structure
- Charges with holder and property details
- Legal cases, compliance and MCA filings
- One PDF report, delivered after checkout
Financials of Beyond Antibody LLP FY 2025 filings available
Financial Statement Summary of Beyond Antibody LLP
| Statement of Account and Solvency | FY 2024-25 | FY 2023-24 | FY 2022-23 | FY 2021-22 | FY 2020-21 |
|---|---|---|---|---|---|
| Income and Expenditure | |||||
| Turnover | •••• | •••• | •••• | •••• | •••• |
| Other Income | •••• | •••• | •••• | •••• | •••• |
| Total Income | •••• | •••• | •••• | •••• | •••• |
| Purchases and Direct Costs | •••• | •••• | •••• | •••• | •••• |
| Personnel Expenses | •••• | •••• | •••• | •••• | •••• |
| Administrative Expenses | •••• | •••• | •••• | •••• | •••• |
| Interest | •••• | •••• | •••• | •••• | •••• |
| Depreciation | •••• | •••• | •••• | •••• | •••• |
| Total Expenses | •••• | •••• | •••• | •••• | •••• |
| Profit Before Tax | •••• | •••• | •••• | •••• | •••• |
| Tax | •••• | •••• | •••• | •••• | •••• |
| Profit After Tax | •••• | •••• | •••• | •••• | •••• |
| Profit Transferred to Partners | •••• | •••• | •••• | •••• | •••• |
| Assets and Liabilities | |||||
| Partners' Contribution | •••• | •••• | •••• | •••• | •••• |
| Reserves and Surplus | •••• | •••• | •••• | •••• | •••• |
| Secured Loans | •••• | •••• | •••• | •••• | •••• |
| Unsecured Loans | •••• | •••• | •••• | •••• | •••• |
| Trade Payables | •••• | •••• | •••• | •••• | •••• |
| Other Liabilities and Provisions | •••• | •••• | •••• | •••• | •••• |
| Total Liabilities | •••• | •••• | •••• | •••• | •••• |
| Fixed Assets | •••• | •••• | •••• | •••• | •••• |
| Investments | •••• | •••• | •••• | •••• | •••• |
| Loans and Advances | •••• | •••• | •••• | •••• | •••• |
| Inventories | •••• | •••• | •••• | •••• | •••• |
| Trade Receivables | •••• | •••• | •••• | •••• | •••• |
| Cash and Bank Balance | •••• | •••• | •••• | •••• | •••• |
| Total Assets | •••• | •••• | •••• | •••• | •••• |
Financial Ratios of Beyond Antibody LLP
| Statement of Account and Solvency | FY 2024-25 | FY 2023-24 | FY 2022-23 | FY 2021-22 | FY 2020-21 |
|---|---|---|---|---|---|
| Profitability | |||||
| Net Profit Margin | •••• | •••• | •••• | •••• | •••• |
| Return on Partners' Funds | •••• | •••• | •••• | •••• | •••• |
| Return on Assets | •••• | •••• | •••• | •••• | •••• |
| Liquidity and Debt | |||||
| Current Ratio | •••• | •••• | •••• | •••• | •••• |
| Debt to Partners' Funds | •••• | •••• | •••• | •••• | •••• |
| Interest Coverage | •••• | •••• | •••• | •••• | •••• |
| Efficiency and Growth | |||||
| Asset Turnover | •••• | •••• | •••• | •••• | •••• |
| Receivable Days | •••• | •••• | •••• | •••• | •••• |
| Turnover Growth | •••• | •••• | •••• | •••• | •••• |
| Profit Growth | •••• | •••• | •••• | •••• | •••• |
Paid data: the figures shown as dots are available after purchase of the company report. Figures as filed with the MCA in Form 8. The full year-wise statements and ratios of Beyond Antibody are in the company report.
Financial statements from FY 2017
Earlier years and trend charts are in the company report.
- Income statements
- Balance sheets
- Cash-flow statements
- Ratios and benchmarks
Verified entity values are shown only after access is granted.
Designated Partners of Beyond Antibody LLP
Beyond Antibody has 2 designated partners on record. No former designated partners are listed.
| Name | Designation | Appointment Date | Tenure | Status |
|---|---|---|---|---|
| Manjula Das | Designated Partner | 20 Apr 2016 | 10 Years 5 Months | Current |
| Sujan Kumar Dhar | Designated Partner | 20 Apr 2016 | 10 Years 5 Months | Current |
Charges & Borrowings of Beyond Antibody LLP
Beyond Antibody LLP does not have any charges (loans) registered with the Registrar of Companies.
Associated Brands with Beyond Antibody LLP
Beyond Antibody operates one associated brand: Beyond Antibody. Each brand links to its own profile.
| Brand | Description | Website |
|---|---|---|
| Bioservices company providing bioassays, drug testing, and characterization for biopharmaceuticals. | beyondantibody.com |
Employees and EPFO Compliance at Beyond Antibody LLP
Employment history and EPFO contributions of people linked to Beyond Antibody.
Employee and EPFO history
Monthly headcount, contribution history and filing status are in the company report.
- Monthly headcount
- PF contributions
- ECR filing status
- Establishment history
Verified entity values are shown only after access is granted.
Recent Activity on Beyond Antibody LLP
Beyond Antibody LLP has 2 designated partner changes on record since 2016: 2 appointments. The latest: Manjula Das was appointed as Designated Partner on 20 Apr 2016.
Credit Ratings, Litigation & Regulatory Alerts for Beyond Antibody LLP
Credit ratings, litigation, and regulatory alerts
Credit ratings, court records and regulatory alerts are in the company report.
- Rating history
- Court and tribunal cases
- Regulatory alerts
- Director-linked violations
Verified entity values are shown only after access is granted.
MSME Payment Delays by Beyond Antibody LLP
MSME payment history
Amounts due to small suppliers, the reasons given and MSME-1 filings are in the company report.
- Outstanding amounts
- Delay periods and reasons
- MSME-1 filing history
- Vendor payment signals
Verified entity values are shown only after access is granted.
Subsidiaries & Group Companies of Beyond Antibody LLP
Corporate group structure
Parent, subsidiary, associate and joint venture records with holdings are in the company report.
- Parent company
- Subsidiaries and ownership
- Associates and joint ventures
- Entity investments
Verified entity values are shown only after access is granted.
GST Compliance of Beyond Antibody LLP
Beyond Antibody has 2 GST registrations: 1 active and 1 cancelled or inactive.
| GSTIN | State | Status | Registered on |
|---|---|---|---|
| 29AAQFB3050P2ZV | Karnataka | Active | 31 Aug 2017 |
GST registrations and filing compliance
State-wise GST registrations, return filing status and HSN or SAC codes are in the company report.
- GSTIN registrations
- State-wise filing status
- HSN and SAC details
- Tax jurisdiction records
Verified entity values are shown only after access is granted.
MCA Filings & Documents of Beyond Antibody LLP
MCA filings and documents
Filed forms, annual returns, financial statements and charge filings with their dates are in the company report.
- Incorporation documents
- Annual returns and statements
- Charge filings
- Complete filing index
Verified entity values are shown only after access is granted.
Frequently Asked Questions about Beyond Antibody LLP
Beyond Antibody is an active limited liability partnership based in Bangalore, Karnataka, India. The LLP works in the research and development industry. It was incorporated on 20 April 2016 (10+ years old) and is registered under LLPIN AAG-1989.
Beyond Antibody has 2 current designated partners:
- Manjula Das - Designated Partner
- Sujan Kumar Dhar - Designated Partner
The GSTIN of Beyond Antibody is 29AAQFB3050P2ZV, registered in Karnataka. The LLP has 2 GST registrations in all, of which 1 is active and 1 is cancelled or inactive.
The LLPIN (Limited Liability Partnership Identification Number) of Beyond Antibody is AAG-1989. It is issued by the Ministry of Corporate Affairs and uniquely identifies the LLP in India.
Beyond Antibody was incorporated on 20 April 2016, making it 10+ years old. It is registered with the Registrar of Companies, Bangalore.
Manjula Das was appointed as Designated Partner on 20 Apr 2016. Sujan Kumar Dhar was appointed as Designated Partner on 20 Apr 2016.
The registered office of Beyond Antibody is at S – 005 Krishna Greens Krishna Temple Road Dodda Bommasandra, Bangalore, Karnataka, India – 560097.
The total obligation of contribution is ₹1 Lakh.
Beyond Antibody operates in the research and development industry.
Beyond Antibody has 1 associated brand: Beyond Antibody.